Pulse oximetry sensor switchover

Information

  • Patent Grant
  • 8068890
  • Patent Number
    8,068,890
  • Date Filed
    Friday, September 29, 2006
    19 years ago
  • Date Issued
    Tuesday, November 29, 2011
    14 years ago
Abstract
Switchover of a filtered and unfiltered pulse oximetry sensor is provided with gain controlled amplifiers controlled by separate gain control voltages that may change in opposite directions over a period of time. The outputs of the gain controlled amplifiers may be coupled to voltage-to-current converters whose outputs may be coupled in parallel. The parallel coupled outputs of the voltage-to-current converters may produce a current signal representative of the output of the gain controlled amplifier having the highest gain/signal.
Description
TECHNICAL FIELD

The present disclosure relates generally to pulse oximetry and, more particularly to switching photodetector sensor output filtering in an oximeter.


BACKGROUND

This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present invention, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of the various aspects of the present invention. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.


Pulse oximetry is a non-invasive method of monitoring the percentage of hemoglobin (hereinafter “Hb”) that is saturated with oxygen. A pulse oximeter may include of a pheripheral probe linked to a monitor that may be microprocessor controlled. The probe may be placed on a peripheral part of the body such as a digit (e.g., one finger or toe), ear lobe or nose. Within the probe, there are typically two light emitting diodes (LEDs), one in the visible red spectrum (e.g., 660 nm) and the other in the infrared spectrum (e.g., 940 nm). Using a transmission type sensor, these two beams of light pass through tissue to a photodetector. During passage through tissue, some light is absorbed by blood and soft tissue depending on the concentration of Hb. The amount of light absorption at each light wavelength depends on the degree of oxygenation of Hb within the tissue. By calculating the light absorption at the two wavelengths, the microprocessor of the monitor may compute the proportion of oxygenated Hb. A microprocessor of an oximeter may average oxygen saturation values over five to twenty seconds. The pulse rate may also be calculated from the number of LED cycles between successive pulsatile signals and averaged over a similar variable period of time, depending on the particular oximeter. A monitor may display the percentage of oxygen saturated Hb together with an audible signal for each pulse beat, a calculated heart rate, and in some monitors, a graphical display of the blood flow past the probe. User programmable audible alarms may also be provided.


From the proportions of light absorbed at each light wavelength, the microprocessor may calculate an estimation of the patient's SpO2 level. The monitor may then display the oxygen saturation digitally as a percentage and/or audibly as a tone of varying pitch.


Reflection pulse oximetry uses reflected, rather than transmitted, light on a single-sided sensor. It can therefore be used proximally anatomically, e.g., on the forehead or bowel, although it may be difficult to secure. Other than using specific reflection spectra, the principles are generally the same as for transmission oximetry.


Oximeters may be calibrated during manufacture and may automatically check internal circuits when turned on. Oximeters may be accurate in the range of oxygen saturations of about 70% to 100% (+/ −2%), but may be less accurate under 70%. The pitch of the audible pulse signal may fall in reducing values of saturation. The size of the pulse wave (related to flow) may be displayed graphically. Some models automatically increase the gain of the display when the flow decreases, but in these models, the display may prove misleading. The alarms usually respond to a slow or fast pulse rate or an oxygen saturation below 90%. At this level, there may be a 30 marked fall in PaO2 representing serious hypoxia.


SUMMARY

Certain aspects commensurate in scope with the originally claimed invention are set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of certain forms the invention might take and that these aspects are not intended to limit the scope of the invention. Indeed, the invention may encompass a variety of aspects that may not be set forth below.


According to a specific example embodiment of this disclosure, an apparatus for switchover of a pulse oximetry sensor may comprise: a pulse oximetry sensor; a first gain controlled amplifier having an input coupled to the pulse oximetry sensor; a digital filter having an analog input coupled to the pulse oximetry sensor; a second gain controlled amplifier having an input coupled to an analog output of the digital filter; a first voltage-to-current converter having a voltage input coupled to an output of the first gain controlled amplifier; a second voltage-to-current converter having a voltage input coupled to an output of the second gain controlled amplifier; the first and second voltage-to-current converters having outputs coupled together to produce a single current output; and a controller having a first gain control output coupled to the first gain controlled amplifier and a second gain control output coupled to the second gain controlled amplifier, wherein the controller may increase the gain of one of the gain controlled amplifiers over a period of time while decreasing the gain of the other gain controlled amplifier over the same period of time, so that the single current output from the first and second voltage-to-current converters represents the output of the gain controlled amplifier having the highest gain.


According to another specific example embodiment of this disclosure, a method of manufacturing a pulse oximeter may comprise providing a first gain controlled amplifier to which a pulse oximetry sensor may be coupled; coupling the pulse oximetry sensor to a digital filter; coupling the digital filter to a second gain controlled amplifier; coupling the first gain controlled amplifier to a first voltage-to-current converter; coupling the second gain controlled amplifier to a second voltage-to-current converter; and coupling the first and second voltage-to-current converter outputs together to produce a current output wherein the gain of one of the gain controlled amplifiers is adapted to increase over a period of time while the gain of the other gain controlled amplifier is adapted to decrease over the same period of time so that the current output from the first and second voltage-to-current converters represents the gain controlled amplifier having the highest gain.


According to yet another specific example embodiment of this disclosure, a pulse oximeter system having a switchover between unfiltered and filtered channels coupled to a pulse oximetry sensor may comprise: a pulse oximetry sensor; an unfiltered channel comprising a first gain controlled amplifier having an input coupled to the pulse oximetry sensor, and a first voltage-to-current converter having a voltage input coupled to an output of the first gain controlled amplifier; a filtered channel comprising a digital filter having an analog input coupled to the pulse oximetry sensor, a second gain controlled amplifier having an input coupled to an analog output of the digital filter, and a second voltage-to-current converter having a voltage input coupled to an output of the second gain controlled amplifier; the first and second voltage-to-current converters having outputs coupled together to produce a single current output; and a controller having a first gain control output coupled to the first gain controlled amplifier and a second gain control output coupled to the second gain controlled amplifier, wherein when the unfiltered channel is selected the controller may increase the gain of the first gain controlled amplifier over a period of time while decreasing the gain of the second gain controlled amplifier over the same period of time so that the single current output from the first and second voltage-to-current converters represents an unfiltered and amplified signal from the pulse oximetry sensor; and when the filtered channel is selected the controller may increase the gain of the second gain controlled amplifier over a period of time while decreasing the gain of the first gain controlled amplifier over the same period of time so that the single current output from the first and second voltage-to-current converters represents a filtered and amplified signal from the pulse oximetry sensor.





BRIEF DESCRIPTION OF THE DRAWINGS

A more complete understanding of the present disclosure may be acquired by referring to the following description taken in conjunction with the accompanying drawings wherein:



FIG. 1 is a schematic block diagram of a switchover, two channel, gain controlled oximeter sensor amplifier having a current output, according to a specific example embodiment of the present disclosure; and



FIG. 2 is a detailed schematic block diagram of a switchover, two channel, gain controlled oximeter sensor amplifier having a current output, according to another specific example embodiment of the present disclosure.





While the present disclosure is susceptible to various modifications and alternative forms, specific example embodiments thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the description herein of specific example embodiments is not intended to limit the disclosure to the particular forms disclosed herein, but on the contrary, this disclosure is to cover all modifications and equivalents as defined by the appended claims.


DETAILED DESCRIPTION

During testing or use of oximeters, a need exists for an improved method to switch between photodetectors and/or different signal processing paths of a photodetector. Heretofore known switching between photo detectors and/or different signal processing paths of a photodetector has introduced undesirable signal transients that may set off oximeter monitor alarms and/or require longer periods of time for the transient to settle out of the normal five to twenty seconds averaging performed by a microprocessor of an oximeter monitor.


Accordingly, there is a need for improved methods, materials, and/or equipment to switch between photo detectors and/or different signal processing paths of a photo detector, e.g., unfiltered and filtered channels of a pulse oximetry sensor.


Referring now to the drawings, the details of specific example embodiments are schematically illustrated. Like elements in the drawings are represented by like numbers, and similar elements are represented by like numbers with a different lower case letter suffix.


Referring to FIG. 1, depicted is a schematic block diagram of a switchover, two channel, gain controlled oximeter sensor amplifier having a current output, according to a specific example embodiment of the present disclosure. A channel 1 input signal 102 may be applied to a gain controlled amplifier 114, and a channel 2 input signal 108 may be applied to a gain controlled amplifier 116. Gains of the gain controlled amplifiers 114 and 116 may be controlled by gain control signal lines 106 and 112, respectively. The outputs 118 and 120 of the gain controlled amplifiers 114 and 116, respectively, are coupled to voltage-to-current converters 122 and 124, respectively. The current outputs of voltage-to-current converters 122 and 124 may be connected in parallel so as to generate a single switchover output current signal 126. Voltage-to-current converters 122 and 124 may be, for example, but not limited to, optical isolators each having a voltage controlled light emitting diode as an input and a photodetector as an output.


For example, at the beginning of a time period T, gain control signal line 106 has a control voltage 104 at a maximum V1 thereby setting the gain of gain controlled amplifier 114 to a maximum. As the time period T proceeds, control voltage 104 decreases until it is at a minimum V1, thereby reducing the gain of gain controlled amplifier 114. In a similar, but opposite fashion, gain control signal line 112 has a control voltage 110 that starts at the beginning of the time period T at a minimum V2 which may set the gain of gain controlled amplifier 116 to a minimum, and as the time period T proceeds, control voltage 110 increases until it is at a maximum V2, thereby, according to an embodiment, increasing the gain of gain controlled amplifier 116. Output current 126, according to an embodiment, represents the dominate gain controlled amplifier output signal 118 or 120, e.g., the one having the highest gain and signal input will block the other one. Thus, input signal transfer may switch from one of the input channels to the other without introducing a transient in the output current signal 126.


Referring to FIG. 2, depicted is a detailed schematic block diagram of a switchover, two channel, gain controlled oximeter sensor amplifier having a current output, according to another specific example embodiment of the present disclosure. A pulse oximetry peripheral probe 202 may comprise two light emitting diodes (LEDs), one in the visible red spectrum (e.g., 660 nm), and the other in the infrared spectrum (e.g., 940 nm). The sources of light from the two LEDs 230 pass through patient tissues to photodetector 232. Light wavelengths not absorbed by the tissues and blood supply are detected by photodetector 232. A current-to-voltage converter 204 receives the current source signal from detector 232 and produces a voltage on signal line 102 that represents the amplitudes of the detected light wavelengths. A signal line 102 is coupled to an input of the gain controlled amplifier 114 and an input of an analog-to-digital converter 226.


The output of analog-to-digital converter 226 may be coupled to a digital filter 224 that may be used to enhance the signal information from the photo-detector 232. A digital-to-analog converter 222 may be coupled to the output of a digital filter 224 so as to convert this output to an analog voltage that may be coupled to an input of gain controlled amplifier 116. According to this specific example embodiment, the photodetector 232 may have an output that may be coupled directly (or indirectly) to the input of the gain controlled amplifier 114. In addition, the output of the photodetector 232 may be coupled (e.g., indirectly) to the gain controlled amplifier 116 through the digital filter 224. This particular embodiment is directed, in one aspect, to providing a switchover between signal line 102 having the unprocessed information from the photodetector 232 and the signal line 108 having the digitally filtered (enhanced) information from the photodetector 232.


The controller 216, e.g., a digital processor, a microprocessor, a microcontroller, a digital signal processor (DSP), an application specific integrated circuit (ASIC) and/or programmable logic array (PLA), in combination with digital-to-analog converters 218 and 220 may be used for controlling gains of the gain controlled amplifiers 114 and 116. When a selection change, e.g., nurse or doctor initiated, is made between the unfiltered and filtered signal information from the photodetector 232, the gain control signal line 106 may have a control signal from the digital-to-analog converter 220 that is at a maximum voltage at the beginning of a time period T, thereby, according to this embodiment, setting the gain of the gain controlled amplifier 114 to a maximum. As the time period T proceeds, the control signal on the gain control signal line 106 decreases until it is at a minimum, thereby, according to this embodiment, reducing the gain of gain controlled amplifier 114. In a similar, but opposite fashion, the gain control signal line 112 may have a control signal that starts at the beginning of the time period T at a minimum voltage thereby, according to this embodiment, setting the gain of the gain controlled amplifier 116 to a minimum, and as the time period T proceeds, the control signal on the gain control signal line 112 increases until it is at a maximum voltage, thereby, according to this embodiment, increasing the gain of the gain controlled amplifier 116.


Since the outputs of the voltage-to-current converters 122 and 124 may be in parallel, the output current 126 may represent the dominant gain controlled amplifier output signal 118 or 120, e.g., the one having the highest gain and signal input will block the other one. Thus, according to this embodiment, input signals 102 and 108 may be switched without introducing a transient in the output current signal 126. The output current signal 126 may be used to supply sensor information to an oximeter 212, e.g., oximeter display monitor. The timing and clocking circuit 228 may be used for clock signals and timing signals for the light emitting diodes 230 and the controller 216.


While embodiments of this disclosure have been depicted, described, and are defined by reference to example embodiments of the disclosure, such references do not imply a limitation on the disclosure, and no such limitation is to be inferred. The subject matter disclosed is capable of considerable modification, alteration, and equivalents in form and function, as will occur to those ordinarily skilled in the pertinent art and having the benefit of this disclosure. The depicted and described embodiments of this disclosure are examples only, and are not exhaustive of the scope of the disclosure.

Claims
  • 1. A pulse oximetry switching system, the system comprising: a pulse oximetry sensor;a first gain controlled amplifier having an input coupled to the pulse oximetry sensor;a digital filter having an analog input coupled to the pulse oximetry sensor;a second gain controlled amplifier having an input coupled to an analog output of the digital filter;a first voltage-to-current converter having a voltage input coupled to an output of the first gain controlled amplifier;a second voltage-to-current converter having a voltage input coupled to an output of the second gain controlled amplifier, wherein the first and second voltage-to-current converters have outputs coupled together to produce a single current output; anda controller having a first gain control output coupled to the first gain controlled amplifier and a second gain control output coupled to the second gain controlled amplifier, the controller adapted to control a gain increase of one of the gain controlled amplifiers over a period of time and a gain decrease of the other gain controlled amplifier over the same period of time, wherein the single current output from the first and second voltage-to-current converters represents the output of the gain controlled amplifier having the highest gain.
  • 2. The apparatus according to claim 1, wherein a current output from the first and second voltage-to-current converters is coupled to an oximeter.
  • 3. The apparatus according to claim 2, wherein the oximeter indicates percent oxygen saturation of blood.
  • 4. The apparatus according to claim 2, wherein the oximeter indicates pulse rate.
  • 5. The apparatus according to claim 3, wherein the pulse oximetry sensor is adapted to attach to a portion of a patient having blood flow therein and wherein the pulse oximetry sensor monitors oxygen saturation of the blood.
  • 6. The apparatus according to claim 1, wherein the pulse oximetry sensor is coupled to the input of the first gain controlled amplifier and the input of the digital filter with a current-to-voltage converter.
  • 7. The apparatus according to claim 1, wherein the pulse oximetry sensor is coupled to the digital filter with an analog-to-digital converter.
  • 8. The apparatus according to claim 1, wherein the analog output of the digital filter is produced with a digital-to-analog converter.
  • 9. The apparatus according to claim 1, wherein the controller comprises at least one of a digital processor, a microprocessor, a microcontroller, a digital signal processor, an application specific integrated circuit, or a programmable logic array, or any combination thereof.
  • 10. The apparatus according to claim 9, wherein the first and second gain control outputs of the microprocessor are produced with first and second digital-to-analog converters, respectively.
  • 11. The apparatus according to claim 1, wherein the current outputs of the first and second voltage-to-current converters are connected in parallel.
  • 12. The apparatus according to claim 1, wherein the controller selects an operational channel for the pulse oximetry sensor by increasing the gain of the gain controlled amplifier associated with that operational channel.
  • 13. A method of manufacturing a pulse oximeter, the method comprising: providing a first gain controlled amplifier to which a pulse oximetry sensor may be coupled;coupling the pulse oximetry sensor to a digital filter;coupling the digital filter to a second gain controlled amplifier;coupling the first gain controlled amplifier to a first voltage-to-current converter;coupling the second gain controlled amplifier to a second voltage-to-current converter; andcoupling the first and second voltage-to-current converter outputs together to produce a current output, wherein by providing a controller the gain of one of the gain controlled amplifiers is adapted to increase over a period of time while the gain of the other gain controlled amplifier is adapted to decrease over the same period of time, wherein the current output from the first and second voltage-to-current converters represents the gain controlled amplifier having the highest gain.
  • 14. The method according to claim 13, comprising coupling the current output of the first and second voltage-to-current converters to an oximeter.
  • 15. The method according to claim 14, wherein the oximeter indicates percent oxygen saturation of blood.
  • 16. The method according to claim 14, wherein the oximeter indicates pulse rate.
  • 17. The method according to claim 13, wherein coupling the pulse oximetry sensor to the first gain controlled amplifier and the digital filter is via a current-to-voltage converter.
  • 18. The method according to claim 13, wherein the pulse oximetry sensor is coupled to the digital filter with an analog-to-digital converter.
  • 19. The method according to claim 13, wherein the controller comprises at least one of a digital processor, a microprocessor, a microcontroller, a digital signal processor, an application specific integrated circuit, or a programmable logic array, or any combination thereof.
  • 20. A pulse oximeter channel switching system, the system comprising: a pulse oximetry sensor;an unfiltered channel comprising a first gain controlled amplifier having an input coupled to the pulse oximetry sensor, anda first voltage-to-current converter having a voltage input coupled to an output of the first gain controlled amplifier;a filtered channel comprising a digital filter having an analog input coupled to the pulse oximetry sensor,a second gain controlled amplifier having an input coupled to an analog output of the digital filter, anda second voltage-to-current converter having a voltage input coupled to an output of the second gain controlled amplifier;the first and second voltage-to-current converters having outputs coupled together to produce a single current output; anda controller having a first gain control output coupled to the first gain controlled amplifier and a second gain control output coupled to the second gain controlled amplifier,wherein the system is configured so that (i) upon selection of the unfiltered channel, the controller increases the gain of the first gain controlled amplifier over a period of time and deceases the gain of the second gain controlled amplifier over the same period of time so that the single current output from the first and second voltage-to-current converters represents an unfiltered and amplified signal from the pulse oximetry sensor; and(ii) upon selection of the filtered channel, the controller increases the gain of the second gain controlled amplifier over a period of time and deceases the gain of the first gain controlled amplifier over the same period of time so that the single current output from the first and second voltage-to-current converters represents a filtered and amplified signal from the pulse oximetry sensor.
  • 21. The system according to claim 20, wherein the controller comprises at least one of a digital processor, a microprocessor, a microcontroller, a digital signal processor, an application specific integrated circuit, or a programmable logic array, or any combination thereof.
US Referenced Citations (194)
Number Name Date Kind
3638640 Shaw Feb 1972 A
4714341 Hamaguri et al. Dec 1987 A
4800885 Johnson Jan 1989 A
4805623 Jöbsis Feb 1989 A
4807631 Hersh et al. Feb 1989 A
4819646 Cheung et al. Apr 1989 A
4846183 Martin Jul 1989 A
4911167 Corenman et al. Mar 1990 A
4913150 Cheung et al. Apr 1990 A
4936679 Mersch Jun 1990 A
4938218 Goodman et al. Jul 1990 A
4971062 Hasebe et al. Nov 1990 A
4972331 Chance Nov 1990 A
4974591 Awazu et al. Dec 1990 A
5028787 Rosenthal et al. Jul 1991 A
5065749 Hasebe et al. Nov 1991 A
5084327 Stengel Jan 1992 A
5119815 Chance Jun 1992 A
5122974 Chance Jun 1992 A
5167230 Chance Dec 1992 A
5190038 Polson et al. Mar 1993 A
5246003 DeLonzor Sep 1993 A
5247931 Norwood Sep 1993 A
5263244 Centa et al. Nov 1993 A
5275159 Griebel Jan 1994 A
5279295 Martens et al. Jan 1994 A
5297548 Pologe Mar 1994 A
5348004 Hollub Sep 1994 A
5355880 Thomas et al. Oct 1994 A
5372136 Steuer et al. Dec 1994 A
5385143 Aoyagi Jan 1995 A
5390670 Centa et al. Feb 1995 A
5413099 Schmidt et al. May 1995 A
5469845 DeLonzor et al. Nov 1995 A
5482036 Diab et al. Jan 1996 A
5483646 Uchikoga Jan 1996 A
5553614 Chance Sep 1996 A
5564417 Chance Oct 1996 A
5575285 Takanashi et al. Nov 1996 A
5611337 Bukta Mar 1997 A
5630413 Thomas et al. May 1997 A
5645059 Fein et al. Jul 1997 A
5645060 Yorkey Jul 1997 A
5680857 Pelikan et al. Oct 1997 A
5692503 Keunstner Dec 1997 A
5730124 Yamauchi Mar 1998 A
5758644 Diab et al. Jun 1998 A
5779631 Chance Jul 1998 A
5782757 Diab et al. Jul 1998 A
5786592 Hök Jul 1998 A
5830136 DeLonzor et al. Nov 1998 A
5830139 Abreu Nov 1998 A
5842981 Larsen et al. Dec 1998 A
5871442 Madarasz et al. Feb 1999 A
5873821 Chance et al. Feb 1999 A
5995856 Mannheimer et al. Nov 1999 A
6011986 Diab et al. Jan 2000 A
6064898 Aldrich May 2000 A
6081742 Amano et al. Jun 2000 A
6088607 Diab et al. Jul 2000 A
6120460 Abreu Sep 2000 A
6134460 Chance Oct 2000 A
6150951 Olejniczak Nov 2000 A
6154667 Miura et al. Nov 2000 A
6163715 Larsen et al. Dec 2000 A
6181958 Steuer et al. Jan 2001 B1
6181959 Schöllermann et al. Jan 2001 B1
6230035 Aoyagi et al. May 2001 B1
6266546 Steuer et al. Jul 2001 B1
6285895 Ristolainen et al. Sep 2001 B1
6312393 Abreu Nov 2001 B1
6353750 Kimura et al. Mar 2002 B1
6397091 Diab et al. May 2002 B2
6415236 Kobayashi et al. Jul 2002 B2
6419671 Lemberg Jul 2002 B1
6438399 Kurth Aug 2002 B1
6461305 Schnall Oct 2002 B1
6466809 Riley Oct 2002 B1
6487439 Skladnev et al. Nov 2002 B1
6501974 Huiku Dec 2002 B2
6501975 Diab et al. Dec 2002 B2
6526301 Larsen et al. Feb 2003 B2
6544193 Abreu Apr 2003 B2
6546267 Sugiura et al. Apr 2003 B1
6549795 Chance Apr 2003 B1
6580086 Schulz et al. Jun 2003 B1
6591122 Schmitt Jul 2003 B2
6594513 Jobsis et al. Jul 2003 B1
6606509 Schmitt Aug 2003 B2
6615064 Aldrich Sep 2003 B1
6622095 Kobayashi et al. Sep 2003 B2
6654621 Palatnik et al. Nov 2003 B2
6658277 Wasserman Dec 2003 B2
6662030 Khalil et al. Dec 2003 B2
6671526 Aoyagi et al. Dec 2003 B1
6671528 Steuer et al. Dec 2003 B2
6678543 Diab et al. Jan 2004 B2
6690958 Walker et al. Feb 2004 B1
6708048 Chance Mar 2004 B1
6711424 Fine et al. Mar 2004 B1
6711425 Reuss Mar 2004 B1
6785568 Chance Aug 2004 B2
6793654 Lemberg Sep 2004 B2
6801797 Mannheimer et al. Oct 2004 B2
6801798 Geddes et al. Oct 2004 B2
6801799 Mendelson Oct 2004 B2
6829496 Nagai et al. Dec 2004 B2
6873865 Steuer et al. Mar 2005 B2
6889153 Dietiker May 2005 B2
6896661 Dekker et al. May 2005 B2
6939307 Dunlop Sep 2005 B1
6949081 Chance Sep 2005 B1
6961598 Diab Nov 2005 B2
6983178 Fine et al. Jan 2006 B2
6996427 Ali et al. Feb 2006 B2
7001337 Dekker et al. Feb 2006 B2
7024233 Ali et al. Apr 2006 B2
7024235 Melker et al. Apr 2006 B2
7027849 Al-Ali Apr 2006 B2
7035697 Brown Apr 2006 B1
7047056 Hannula et al. May 2006 B2
7127278 Melker et al. Oct 2006 B2
7130671 Baker, Jr. et al. Oct 2006 B2
7162288 Nordstrom et al. Jan 2007 B2
7209775 Bae et al. Apr 2007 B2
7236811 Schmitt Jun 2007 B2
7263395 Chan et al. Aug 2007 B2
7267652 Coyle et al. Sep 2007 B2
7272426 Schmid Sep 2007 B2
7440788 Jenkins et al. Oct 2008 B2
20010005773 Larsen et al. Jun 2001 A1
20010020122 Steuer et al. Sep 2001 A1
20010039376 Steuer et al. Nov 2001 A1
20010044700 Kobayashi et al. Nov 2001 A1
20020026106 Khalil et al. Feb 2002 A1
20020035318 Mannheimer et al. Mar 2002 A1
20020038079 Steuer et al. Mar 2002 A1
20020042558 Mendelson Apr 2002 A1
20020049389 Abreu Apr 2002 A1
20020062071 Diab et al. May 2002 A1
20020111748 Kobayashi et al. Aug 2002 A1
20020133068 Huiku Sep 2002 A1
20020156354 Larson Oct 2002 A1
20020161287 Schmitt Oct 2002 A1
20020161290 Chance Oct 2002 A1
20020165439 Schmitt Nov 2002 A1
20020198443 Ting Dec 2002 A1
20030023140 Chance Jan 2003 A1
20030055324 Wasserman Mar 2003 A1
20030060693 Monfre et al. Mar 2003 A1
20030139687 Abreu Jul 2003 A1
20030141914 Buchwald et al. Jul 2003 A1
20030144584 Mendelson Jul 2003 A1
20030220548 Schmitt Nov 2003 A1
20030220576 Diab Nov 2003 A1
20040010188 Wasserman Jan 2004 A1
20040054270 Pewzner et al. Mar 2004 A1
20040087846 Wasserman May 2004 A1
20040107065 Al-Ali Jun 2004 A1
20040127779 Steuer et al. Jul 2004 A1
20040163648 Burton Aug 2004 A1
20040171920 Mannheimer et al. Sep 2004 A1
20040176670 Takamura et al. Sep 2004 A1
20040176671 Fine et al. Sep 2004 A1
20040230106 Schmitt et al. Nov 2004 A1
20050080323 Kato Apr 2005 A1
20050085735 Baker, Jr. et al. Apr 2005 A1
20050101850 Parker May 2005 A1
20050105554 Kagan et al. May 2005 A1
20050107676 Acosta et al. May 2005 A1
20050113656 Chance May 2005 A1
20050159646 Nordstrom et al. Jul 2005 A1
20050168722 Forstner et al. Aug 2005 A1
20050177034 Beaumont Aug 2005 A1
20050192488 Bryenton et al. Sep 2005 A1
20050203357 Debreczeny et al. Sep 2005 A1
20050228248 Dietiker Oct 2005 A1
20050267346 Faber et al. Dec 2005 A1
20050283059 Iyer et al. Dec 2005 A1
20060009688 Lamego et al. Jan 2006 A1
20060015021 Cheng Jan 2006 A1
20060020181 Schmitt Jan 2006 A1
20060030763 Mannheimer et al. Feb 2006 A1
20060052680 Diab Mar 2006 A1
20060058683 Chance Mar 2006 A1
20060064024 Schnall Mar 2006 A1
20060195025 Ali et al. Aug 2006 A1
20060195028 Hannula et al. Aug 2006 A1
20060224058 Mannheimer Oct 2006 A1
20060247501 Ali Nov 2006 A1
20060258921 Addison et al. Nov 2006 A1
20070208240 Nordstrom et al. Sep 2007 A1
20080082018 Sackner et al. Apr 2008 A1
20080287757 Berson et al. Nov 2008 A1
Foreign Referenced Citations (24)
Number Date Country
102 13 692 Oct 2003 DE
2237544 Sep 1990 JP
3170866 Jul 1991 JP
4332536 Nov 1992 JP
5-212016 Aug 1993 JP
3238813 Oct 1994 JP
8256996 Oct 1996 JP
2003194714 Jul 2003 JP
2003210438 Jul 2003 JP
2004008572 Jan 2004 JP
2004113353 Apr 2004 JP
2004194908 Jul 2004 JP
2004248819 Sep 2004 JP
2004290545 Oct 2004 JP
WO 9220273 Nov 1992 WO
WO9309711 May 1993 WO
WO 9403102 Feb 1994 WO
W09512349 May 1995 WO
WO 9749330 Dec 1997 WO
WO9843071 Oct 1998 WO
WO9932030 Jul 1999 WO
WO0021438 Apr 2000 WO
WO 0145553 Jun 2001 WO
W02006100685 Sep 2006 WO
Related Publications (1)
Number Date Country
20080081970 A1 Apr 2008 US